TSCAN THERAPEUTICS INC
TCRX·89854M101·US·Common Stock·Healthcare - Biotechnology-13D/G
TCRX (TSCAN THERAPEUTICS INC) is held by 38 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.7M), VANGUARD CAPITAL MANAGEMENT LLC ($2.1M), TWO SIGMA INVESTMENTS, LP ($1.9M). Net institutional sentiment: Mixed.
38
Holders
(1 Elite)
$16.1M
Total Value
57% (35)
Consensus
20 buying - 15 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Dec 23, 2025 · Activists Aug 14, 2026 · Congress none
ActivistBLBVF PARTNERS L P/IL10.0%Aug 14, 2026
ActivistLYLynx1 Capital Management LP13.1%Aug 14, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 44
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer